DTU: Kraft Named Positive for EPO A Sample
10923
While the triathlon world awaits a statement from German Nina Kraft, credible sources from around the world confirm Kraft as having tested positive in an A sample for the performance- enhancing drug Erythropoietin from her victory at the Hawaii Ironman
152243
Shares in BiogenIdec (BIIB:Nasdaq - news - research) and Elan (ELN:NYSE - news - research)rose early Monday after the companies released what they described as &quot;compelling&quot; phase III test results for their multiple sclerosis drug Antegren.
64799
Merck&#39;s (nyse: MRK - news - people ) decision is based on new three-year data from a clinical trial designed to test the effect of Vioxx on preventing colorectalpolyps.
261987
Kraft Foods Inc  shares rose on Friday after Warren Buffett's Berkshire Hathaway Inc   revealed it had taken an 8.6 percent stake, making it by far the foodmaker's largest shareholder.
500250
GlaxoSmithKline&#39;s  experimental  platelet-boosting drug eltrombopag has produced further  positive results in patients with idiopathic thrombocytopenia  purpura (ITP), researchers said on Saturday.
696035
Kraft Foods Inc., best known for products like Oreo cookies and macaroni and cheese,  said it is adding the South Beach Diet brand to its portfolio in its latest attempt to address concerns about obesity and health.
725261
There's encouraging news about an enzyme replacement drug.
344165
COLORADO SPRINGS, Colo. -- Albuquerque distance runner Eddy Hellebuyck has been suspended for two years after testing positive for recombinant human erythropoietin, a synthetic hormone, the US Anti-Doping Agency said Thursday.
214133
German cyclist Erik Zabel becomes the latest cyclist to admit to using banned blood booster EPO while competing for Telekom in the 1990s.
756436
THE REGION GTC Biotherapeutics Inc. has won fast-track designation from the Food and Drug Administratrion for ATryn, a protein produced in the milk of goats that has anticoagulant and anti-inflammatory properties. The Framingham company said fast-track designation allows for an accelerated review of ATryn as a treatment for patients with hereditary antithrombin deficiency who are at risk of developing deep ...
86220
Nina Kraft, winner of last month&#39;s Ironman Triathlon World Championship in Hawai&#39;i, acknowledged yesterday that she had used the banned endurance-boosting drug EPO.
289071
Today was a day of good news for multiple sclerosis patients: FDA granted approval to a new anti-multiple sclerosis drug Antegren developed by Biogen Idec Inc.
249746
FRANKFURT: Germany&#39;s Ironman Triathlon world champion Nina Kraft faces losing her title and being banned from competition after admitting using the banned blood booster EPO (erythropoietin).
271543
The Food and Drug Administration strongly endorsed Biogen Idec Inc.'s new multiple sclerosis treatment, putting the Cambridge firm in position to expand the market for MS drugs and win greater market share. The drug, formerly called Antegren but renamed Tysabri, was developed with Elan Pharmaceuticals of Ireland. The FDA approved Tysabri for use on its own and in ...
150108
High circulating levels of a protein called mannan binding lectin (MBL), which prompts scavenger cells to remove various inflammatory agents, appear to reduce the risk of having a heart attack -- especially for people with diabetes -- Icelandic researchers report.
653679
The EU market welcomes the drugmaker's copy of a treatment for anemia.
395555
Better test results for Elan Corp&#39;s key Antegren drug lifted the Irish company&#39;s shares more than 10 percent as analysts said the data improved its chances of becoming the leading multiple sclerosis treatment.